Autonomic Drug Flashcards

1
Q

Onabotulinum toxinA

A

In activates synaptic vesicles protein (SNAP-25), prevents docking with membrane and therefore no ACh release; flaccid paralysis of skeletal muscles; indications: muscle spasms, cosmetic, auxiliary hyperhidrosis, overactive bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Onabotulitum toxin S.E

A

Distant spread beyond injection site; dysphasia and breathing difficulties, ptosis, pain, drooling, loss of facial expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Muscarine

A

Selectively stimulates M1-M5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Atropine

A

Selectively blocks M1-M5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nicotine

A

Stimulates Nn and Nm, blocked by mecamylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

D-tubocurarine

A

Competitive antagonist of Nm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Reserpine

A

Inhibits the storage of catecholamines therefore increases degradation by MAO, depleting nerve terminals and reducing SNS in CNS and periphery; oral anti-HTN and antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tyramine

A

Stimulation of NE release- displaces NE from vesicles and causes non-vesicular release; can elicit a HTN crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Methyldopa

A

Prodrug converted to methyl-NE and is a selective alpha-2 agonist, decreasing SNS outflow to periphery; SE=sedation, dry mouth, Parkinsonism, hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cocaine

A

Inhibition of catecholamines termination, blocks NET allowing for excess SNS stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acetylcholine

A

Non-selective action at M and Nn; IV, short duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bethanechol

A

Prototype ester; selective M agonist, postoperative and postpartum urinary retention, GERD, gastric atony; resistant to hydrolysis by cholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pilocarpine

A

Partial agonist of all muscarinic receptor subtypes; prototype alkaloid; used typically in eyes to produce mitosis and blurred vision, decrease in IOP (xerostomia and wide-angle glaucoma are indications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cevimeline

A

Selective M3 agonist; used to treat dry mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticholinergic side effects

A

“Hot as a hare, dry as a bone, blind as a bat, red as a beet, mad as a hatter”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Scopolamine

A

Muscrarinic antagonist; CNS penetration better than atropine; sedation at low doses; suppresses eyes is and motion sickness by blocking M in vestibular system

17
Q

Ipatropium bromide

A

Muscarinic antagonist that does not cross membranes, stays locally; used as an inhaled broncodilator for treatment of asthma and COPD

18
Q

Tropicamide

A

Muscarinic antagonist; mydriatic and cycloplegic; facilitates diagnosis and surgery of eyes, short length of duration (6 hours)

19
Q

Tolterodine

A

Non-selective muscarinic antagonist; used in the treatment of overactive bladder

20
Q

Neostigmine

A

Anti cholinesterase agent also an agonist at the NMJ; tx for myasthenia gravis to increase ACh levels at NMJ

21
Q

Physostigmine

A

AChE inhibitor; crosses BBB; used to treat poisoning by atropine

22
Q

Donepezil

A

More selective inhibition of AChE isoform in the CNS; used to tx cognitive decline in Alzheimer’s

23
Q

Malathion

A

Irreversible inhibitor of AChE

24
Q

Tx for malathion poisoning

A

Atropine or Pralidoxime (AChE reactivator)

25
Q

Epinephrine

A

(Alpha-1, alpha-2, beta-1, beta-2)

Adrenergic agonist

26
Q

Norepinephrine

A

(Alpha-1, alpha-2, beta-1)

TX: Severe hypotensive states, vasopressin for treatment of septic shock

27
Q

Isoproterenol

A

(Beta-1, beta-2)
Potent, non-selective beta agonist
Tx: AV block and cardiac arrest, broncospasm during anestheisa

28
Q

Dopamine

A

(D1 > beta-1 > alpha-1)
Adrenergic agonist
Tx: treatment of shock if accompanied by low cardiac output, maintain systemic blood pressure in hypotensive patients

29
Q

Dobutamine

A

(Beta-1)
Adrenergic agonist
Increases contractility and heart rate
Tx: short term management of severe refractory CHF

30
Q

Phenylephrine

A

(Alpha 1)
Non-catecholamine adrenergic agonist
Tx: nasal decongestant, vasopressin agent, mydriatic, detumescent

31
Q

Clonidine

A

(Alpha-2)
Non-catecholamine adrenergic agonist
Tx: hypertension, relief of severe pain

32
Q

Terbutaline

A

(Beta-2)
Non-catecholamine adrenergic agonist
Tx: reduces airway resistance in asthmatics with little effect on heart

33
Q

Tamsulosin

A
Adrenergic antagonist (alpha-1a)
Selectively favors blockade in prostate capsule, urethra and bladder neck with little effect on BP
34
Q

Prazosin

A

Alpha Adrenergic antagonist (alpha-1)
Dilates arteries and veins and relaxes smooth muscle of the bladder neck and prostate capsule
Tx: third line agent for hypertension

35
Q

Propranolol

A

Beta Adrenergic antagonists (Beta-1, beta-2)

Pure competitive antagonist: decrease HR and slow impulse conduction through AV node, long term reduces blood pressure

36
Q

Metoprolol

A

Beta Adrenergic antagonist; 2nd generation “cardio selective”; highly selective for beta-1 receptors at therapeutic doses, less likely to causes bronchoconstriction and suppression of glycogenolysis
Tx: HTN, angina, CHF, MI

37
Q

Mecamylamine

A

N(n) antagonist, noncompetative, blocks activation of SNS and PNS nerve fibers, reveals dominant division affecting the tissue; anti-HTN agent